相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)
Giuseppe Procopio et al.
TUMORI JOURNAL (2023)
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Xiashuang Zhao et al.
BMC CANCER (2023)
Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8+IFN-γ+ T cells in atherosclerosis
Qi Li et al.
INFLAMMATION RESEARCH (2023)
Vascular endothelial cell development and diversity
Emily Trimm et al.
NATURE REVIEWS CARDIOLOGY (2023)
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
Nabil F. Saba et al.
NATURE MEDICINE (2023)
Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
Ngar Woon Kam et al.
ANGIOGENESIS (2022)
B Cell Function in the Tumor Microenvironment
Stephanie M. Downs-Canner et al.
ANNUAL REVIEW OF IMMUNOLOGY (2022)
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors
Parvin Akbari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy
Assia Asrir et al.
CANCER CELL (2022)
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
Julia Femel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
NOX1 and NOX2: Two enzymes that promote endothelial-to-mesenchymal transition induced by melanoma conditioned media
Valentin Platel et al.
PHARMACOLOGICAL RESEARCH (2022)
Endothelial cell-specific expression of serine/threonine kinase 11 modulates dendritic cell differentiation
Qiang Zhao et al.
NATURE COMMUNICATIONS (2022)
Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer
Xin Qing et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeting TNFR2 in Cancer: All Roads Lead to Rome
Jingchao Bai et al.
FRONTIERS IN IMMUNOLOGY (2022)
Tumor endothelial cell-induced CD8+ T-cell exhaustion via GPNMB in hepatocellular carcinoma
Yoshihiro Sakano et al.
CANCER SCIENCE (2022)
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi et al.
CELL COMMUNICATION AND SIGNALING (2022)
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 Trial
Jiyun Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
The impact of VEGF on cancer metastasis and systemic disease
Yunlong Yang et al.
SEMINARS IN CANCER BIOLOGY (2022)
The Role of MiR-181 Family Members in Endothelial Cell Dysfunction and Tumor Angiogenesis
Chun Yang et al.
CELLS (2022)
Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming
Makon-Sebastien Njock et al.
JOURNAL OF EXTRACELLULAR VESICLES (2022)
The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells
Hye Won Jun et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy
Peace Mabeta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
Simona Caruso et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells
Ilaria Elia et al.
CELL METABOLISM (2022)
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Andrew X. Zhu et al.
NATURE MEDICINE (2022)
Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation
Katharina E. M. Hellenthal et al.
CELLS (2022)
Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy
Parisa Mohammadi et al.
DRUG METABOLISM REVIEWS (2022)
Tumor buster-where will the CAR-T cell therapy 'missile' go?
Chunrun Qu et al.
MOLECULAR CANCER (2022)
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
Kaiting Yang et al.
NATURE NANOTECHNOLOGY (2022)
Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation
Michelangelo Certo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment
Chenfei Zhou et al.
CELL DEATH AND DIFFERENTIATION (2021)
B7-H3: An Attractive Target for Antibody-based Immunotherapy
Filippos Kontos et al.
CLINICAL CANCER RESEARCH (2021)
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
TingTing Tang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
KRAS G12V mutation upregulates PD-L1 expression via TGF-β/EMT signaling pathway in human non-small-cell lung cancer
Li-Na Pan et al.
CELL BIOLOGY INTERNATIONAL (2021)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
TIM-3: An update on immunotherapy
Lizhen Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in Shb-Deficient Endothelial Cells Increases Tumor Lung Metastasis
Qi He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CD137+ T-Cells: Protagonists of the Immunotherapy Revolution
Alessio Ugolini et al.
CANCERS (2021)
Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation
Jeremie Joffre et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
Chi Yan et al.
MOLECULAR CANCER (2021)
M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2
Yuhan Yang et al.
MOLECULAR THERAPY (2021)
STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis
Ying Shen et al.
SCIENCE SIGNALING (2021)
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
Riyao Yang et al.
NATURE COMMUNICATIONS (2021)
Vascular endothelial cell specification in health and disease
Corina Marziano et al.
ANGIOGENESIS (2021)
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
Filipa Lopes-Coelho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination
Camille L. Duran et al.
CANCERS (2021)
Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Zowi R. Huinen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions AC
Anastasia O. Gkountidi et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation
Shujuan Zhou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
Kenji Hashimoto
CANCERS (2021)
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Sashi Kandel et al.
CANCER LETTERS (2021)
Modulation of the tumor microenvironment (TME) by melatonin
Qi Mu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance
Triet M. Bui et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity
A. Stoll et al.
LEUKEMIA (2021)
Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma
Felix C. Popp et al.
CANCERS (2021)
Calmodulin 2 Facilitates Angiogenesis and Metastasis of Gastric Cancer via STAT3/HIF-1A/VEGF-A Mediated Macrophage Polarization
Ganggang Mu et al.
FRONTIERS IN ONCOLOGY (2021)
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Yanyu Huang et al.
BIOMOLECULES (2021)
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial
Yuankai Shi et al.
CANCER COMMUNICATIONS (2021)
Role of tumor/endothelial cell interactions in tumor growth and metastasis
O.N. Pyaskovskaya et al.
Experimental Oncology (2021)
B7-H3 Immune Checkpoint Protein in Human Cancer
Karine Flem-Karlsen et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
Florent Amatore et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Endothelial Cell Calcium Signaling during Barrier Function and Inflammation
Prarthana J. Dalal et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade
Qian Li et al.
CLINICAL CANCER RESEARCH (2020)
CTLA-4: From mechanism to autoimmune therapy
Arezoo Hosseini et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils
Xichen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression
Ruoqin Wang et al.
CELL DEATH & DISEASE (2020)
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
Dawei Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P. Chao et al.
FRONTIERS IN ONCOLOGY (2020)
TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation
Yasuhiro Yoshimatsu et al.
CANCER SCIENCE (2020)
Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis
Katerina Rohlenova et al.
CELL METABOLISM (2020)
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles
Nausicaa Clemente et al.
JOURNAL OF CONTROLLED RELEASE (2020)
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
Shaochuan Liu et al.
CELL DEATH & DISEASE (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells
Yizi Cong et al.
BIOSCIENCE REPORTS (2020)
Tumor Endothelial Cell-Mediated Antigen-Specific T-cell Suppression via the PD-1/PD-L1 Pathway
Kazuhiro Taguchi et al.
MOLECULAR CANCER RESEARCH (2020)
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
Sujin Kang et al.
POLYMERS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Endothelial-to-Mesenchymal Transition in Cancer
Nicolas Clere et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Osteopontin binds ICOSL promoting tumor metastasis
Davide Raineri et al.
COMMUNICATIONS BIOLOGY (2020)
NOX2-Derived Reactive Oxygen Species in Cancer
Hanna Grauers Wiktorin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells
Yizi Cong et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
CD4 T Helper Cell Subsets and Related Human Immunological Disorders
Xiaoliang Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Kristian M. Hargadon
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
Cinzia Solinas et al.
ESMO OPEN (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Maria Georganaki et al.
ONCOIMMUNOLOGY (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density
Phyu P. Aung et al.
CLINICAL CANCER RESEARCH (2019)
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma-Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression
Sook Shien Lee et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
IFN-gamma and TNF-alpha aggravate endothelial damage caused by CD123-targeted CAR T cell
Yao Sun et al.
ONCOTARGETS AND THERAPY (2019)
Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer
Pawel Bieniasz-Krzywiec et al.
CELL METABOLISM (2019)
Vascular Endothelial Cell Biology: An Update
Anne Krueger-Genge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer
Musbau Adewumi Akanji et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
NK Cell Metabolism and Tumor Microenvironment
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells
Farnaz Hajizadeh et al.
LIFE SCIENCES (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
Interleukin-22 promotes tumor angiogenesis
Nicholas J. Protopsaltis et al.
ANGIOGENESIS (2019)
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Maria Teresa Masucci et al.
FRONTIERS IN ONCOLOGY (2019)
NOX2 in autoimmunity, tumor growth and metastasis
Anna Martner et al.
JOURNAL OF PATHOLOGY (2019)
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Selectins in cancer immunity
Lubor Borsig
GLYCOBIOLOGY (2018)
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Priti S. Hegde et al.
SEMINARS IN CANCER BIOLOGY (2018)
A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells
Sukhbir Kaur et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts
Ju Hun Yeon et al.
ACTA BIOMATERIALIA (2018)
High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
Andreas Seeber et al.
CANCER SCIENCE (2018)
Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model
Ran An et al.
FASEB JOURNAL (2018)
Human T Cell Development, Localization, and Function throughout Life
Brahma V. Kumar et al.
IMMUNITY (2018)
Contribution of Tumor Endothelial Cells in Cancer Progression
Kyoko Hida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Laia Caja et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Deok-Hoon Kong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
Jin Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
Lijuan Wei et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting veGF/veGFR to Modulate Antitumor immunity
Ju Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
IFN gamma-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
Ryan S. Lane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development
Ian P. Harrison et al.
Oncotarget (2018)
Distant Relations: Macrophage Functions in the Metastatic Niche
Geneva R. Doak et al.
TRENDS IN CANCER (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
Lu Gao et al.
ONCOTARGET (2017)
Endothelial cell-cell adhesion and signaling
Camilla Cerutti et al.
EXPERIMENTAL CELL RESEARCH (2017)
Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer
Emilie Uldry et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells
Zhong Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
Hao-Wei Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Xin Chen et al.
SCIENCE SIGNALING (2017)
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
Martina Schmittnaegel et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TNFR2: A Novel Target for Cancer Immunotherapy
Eva S. Vanamee et al.
TRENDS IN MOLECULAR MEDICINE (2017)
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
Alessandra Dondero et al.
ONCOTARGET (2017)
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Thornton W. Thompson et al.
ELIFE (2017)
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Xin Chen et al.
SCIENCE SIGNALING (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
Ana E. Paiva et al.
NEOPLASIA (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
Tumor endothelial cells accelerate tumor metastasis
Nako Maishi et al.
CANCER SCIENCE (2017)
Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer
Song-Chang Lin et al.
DEVELOPMENTAL CELL (2017)
Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA
Quanfeng Wu et al.
CANCER CELL INTERNATIONAL (2017)
Endothelial Notch1 Activity Facilitates Metastasis
Elfriede Wieland et al.
CANCER CELL (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells
Zhongwei Cao et al.
CANCER CELL (2017)
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J. M. Pitt et al.
ANNALS OF ONCOLOGY (2016)
Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation
Natalia Reglero-Real et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1
Wei-Jun Chen et al.
ATHEROSCLEROSIS (2016)
NOX2-dependent regulation of inflammation
Kelly L. Singel et al.
CLINICAL SCIENCE (2016)
Endothelial Progenitor Cells as Shuttle of Anticancer Agents
Anna Laurenzana et al.
HUMAN GENE THERAPY (2016)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Caroline Wigerup et al.
PHARMACOLOGY & THERAPEUTICS (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
Luuk van Hooren et al.
ONCOTARGET (2016)
VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma
Xinqi Wu et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Endothelial cell colony forming units derived from malignant breast diseases are resistant to tumor necrosis factor-α-induced apoptosis
Chen-Pin Chou et al.
SCIENTIFIC REPORTS (2016)
The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF
Emine Salva et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer
Rebecca S. Heist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Monocyte Subpopulations in Angiogenesis
Heather J. Dalton et al.
CANCER RESEARCH (2014)
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Eun-Jin Yeo et al.
CANCER RESEARCH (2014)
Roles of VEGF-A signalling in development, regeneration, and tumours
Ken Matsumoto et al.
JOURNAL OF BIOCHEMISTRY (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
B7-H3 expression in breast cancer and upregulation of VEGF through gene silence
Jing Sun et al.
ONCOTARGETS AND THERAPY (2014)
TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling
Hong Ji et al.
NATURE COMMUNICATIONS (2014)
Antitumor Effects of CD40 Ligand-Expressing Endothelial Progenitor Cells Derived From Human Induced Pluripotent Stem Cells in a Metastatic Breast Cancer Model
Yovita Ida Purwanti et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
Michele Ammendola et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro
Xipeng Wang et al.
CANCER SCIENCE (2013)
Cell Trafficking of Endothelial Progenitor Cells in Tumor Progression
Pilar de la Puente et al.
CLINICAL CANCER RESEARCH (2013)
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Fabien B. Vincent et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice
Hanseul Yanh et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Differentiation of immature DCs into endothelial-like cells in human esophageal carcinoma tissue homogenates
Jing Lu et al.
ONCOLOGY REPORTS (2013)
B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Chunmei Yang et al.
PLOS ONE (2013)
Overexpression of platelet-derived growth factor-B increases the growth, invasion, and angiogenesis of gastric carcinoma cells through protein kinase B
Y. Guo et al.
NEOPLASMA (2013)
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy
D. Y. Heng et al.
ANNALS OF ONCOLOGY (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Stromal Endothelial Cells Establish a Bidirectional Crosstalk with Chronic Lymphocytic Leukemia Cells through the TNF-Related Factors BAFF, APRIL, and CD40L
Montserrat Cols et al.
JOURNAL OF IMMUNOLOGY (2012)
Endothelial Cell Heterogeneity
William C. Aird
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Kelly L. Mueller et al.
BREAST CANCER RESEARCH (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
CD40/CD4OL interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration
Daniel Urban et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium
Dana M. Brantley-Sieders et al.
CANCER RESEARCH (2011)
Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
Asis Palazon et al.
CANCER RESEARCH (2011)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
Wiem Lassoued et al.
CANCER BIOLOGY & THERAPY (2010)
MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma
Jing Lu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
Xiaoyuan Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T cell Functions Through the Production of PGE2
Jennifer K. Mulligan et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Involvement of endothelial progenitor cells in tumor vascularization
Alexandre Patenaude et al.
MICROVASCULAR RESEARCH (2010)
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Xingxing Zang et al.
MODERN PATHOLOGY (2010)
Breaching multiple barriers: leukocyte motility through venular walls and the interstitium
Sussan Nourshargh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions
Jennifer K. Mulligan et al.
HUMAN IMMUNOLOGY (2009)
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Justin B. Maxhimer et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines
H. Kanno et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma
Paul L. Crispen et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions
Jennifer K. Mulligan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoletin-2
Claire E. Lewis et al.
CANCER RESEARCH (2007)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Differentiation of human tumour-associated dendritic cells into endothelial-like cells: An alternative pathway of tumour angiogenesis
E. Gottfried et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Triggering CD40 on endothelial cells contributes to tumor growth
Claudia Chiodoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration
Jiale He et al.
LABORATORY INVESTIGATION (2006)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-α via TNF receptor 2 and autocrine up-regulation of MCP-1
K Jöhrer et al.
CLINICAL CANCER RESEARCH (2004)
Endothelial expression of PD-L1 and PD-L2 down-regulates CD8(+) T cell activation and cytolysis
N Rodig et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)